These formulation differences can theoretically affect absorption rate, which could influence the timing between the injection and peak drug levels
Cold intolerance is not listed among the common adverse effects in the Summary of Product Characteristics for semaglutide (Wegovy) or liraglutide (Saxenda), which typically include gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation), injection site reactions, and headache
M.SpitzD
By increasing the time it takes for food to leave the body, it also slows digestion
How to Tell If a GLP-1 Provider Is Cutting Corners Red Flags: No lab requirement before prescribing Instant approval without medical history review One-size-fits-all dosing plans No follow-up or monitoring protocol Limited or no access to a licensed clinician Patients should feel empowered to ask: What data are you using to determine this is safe for me? Patient Scenarios: Real-World Context Case 1: Undiagnosed Prediabetes A patient begins semaglutide without labs
Best Practices for Wellness Centers A wellness center should use a clear compliance plan